While the SAFE Drugs Act remains under legislative consideration, the FDA and state attorneys general appear to already be implementing more aggressive oversight measures until a more stringent oversight framework is in place
Another choice, Zepbound (tirzepatide), a dual GIP/GLP-1 Agonist, provides enhanced weight loss results by targeting two hormones
When glutathione levels drop, it often shows on the skin as dullness, uneven tone, or early signs of ageing
Liposuction after GLP-1 weight loss is on the rise in 2026 because millions of people who dropped a lot of weight on semaglutide and tirzepatide drugs are now dealing with stubborn fat deposits, loose skin, and alterations in body proportions that no medication can fix
Recently, GLP-1 drugs have become very popular for weight loss